This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Looking for quick cash solutions? Here are effective ways to find cash in just 3 days to help you out in a pinch.
25,350 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Rocket Lab’s stock has faced renewed pressure as the market weighs contracting demand signals and execution risks. Th...
Astera Labs stands at an inflection point: rapid AI demand could lift the stock, but margin pressures and a premium v...
In the first half of 2026, Upstart stock fell about 19%, shaking confidence in a fintech darling. This article breaks...
MIAX is shaping 2026 in a dynamic way, and the first-quarter earnings transcript offers clues about growth drivers an...
ServiceNow faced real headwinds long before the AI hype. This article breaks down the root causes, their impact on ma...
A renewable-powered data-center company, Iren, surged after unveiling a multi-year Nvidia partnership and ambitious A...
The next Fed chair choice could redefine the market landscape. This article breaks down what president donald trump's...
A hypothetical partnership could redirect USDC yield to buybacks, potentially lifting Hyperliquid's value. This guide...
Pfizer is stepping into a high-stakes arena long led by Lilly and Novo Nordisk. This article analyzes what pfizer's w...
As SpaceX gears up for a public listing, investors are watching how the company plans to squeeze more profits from it...
Eli Lilly is shaking up its growth plan by expanding beyond obesity with new infectious disease initiatives. This art...